Popular on eTradeWire
- MAG Magna Corp Targets Trillion-Dollar Opportunity by Tokenizing Rare Earth Assets Critical to AI, EVs, & Defense: MAG Magna Corp.: Stock Symbol: MGNC - 107
- How Toronto Homes Can Stay Safe with Modern Security Systems - 106
- Nancy Anderberg Launches nancyanderberg.com The Official Home of the REinvention Movement - 105
- Potential Recruiting Scams. Industry Veteran Who Helped Hire 400,000 Workers Speaks Out! - 105
- American Design Agency LLC Helps US Businesses Stand Out with Next-Gen Digital Solutions
- Sports Monetize Pivots to Daily Fantasy Sports Content
- Aura Lounge & Bar Set to Launch in Farmingdale, NY — A New Luxury Nightlife Experience Arriving
- Nick Perkins, Chief Strategy Officer of The Digital Ring, Establishes Scalable Growth for Businesses
- On Good Friday, Civil Rights Attorney Pamela Price Condemned "State-Sanctioned Harm" Against Unhoused Black Man
- UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value
Similar on eTradeWire
- Join First Choice Neurology at the 2026 AAN Annual Meeting in Chicago
- One Clean Carton® with Sustainable Paperboard Tests Safe for Secondary Packaging
- Injury Care Clinic Now Offers StemWave Therapy–A Drug-Free, Non-Invasive Solution for Chronic Pain
- Cryolab Launches Expert Comparison Guide for Liquid Nitrogen Storage Vessels
- TVCG Physicians Lead Community Education on Vascular Health Across Massachusetts
- ROC's Dr. Christopher Nanson Sponsors Local High School Auction
- Healthcare Sales Academy Highlights the Affordability of Its MRC and PSC Certifications
- AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
- Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
- As Billions of Dollars Flood Into AI, Rorq sees its Achilles Heel the Market Isn't Pricing
Partners4Access Associate Consultant Johann Sanseau to Present Poster at FSHD Research Congress
eTradeWire News/10806769
LIVERPOOL, U.K. - eTradeWire -- Partners4Access (P4A), a global consultancy specializing in access strategy for orphan and rare diseases, proudly announces that Associate Consultant, Johann Sanseau will present his technical poster at the International Research Congress for Facioscapulohumeral Muscular Dystrophy (FSHD), taking place in Amsterdam this month.
Johann's poster, titled "Optimising Clinical Development Programs for FSHD Therapies in Preparation for Joint Clinical Assessment (JCA) in Europe," explores strategic approaches to aligning FSHD therapy development with the evolving regulatory and health technology assessment (HTA) landscape. As the European Union moves toward centralized JCA processes, Johann's research highlights critical considerations for developers navigating both clinical efficacy and payer expectations.
More on eTradeWire News
The acceptance of this work at one of the leading global forums for FSHD research reflects both Johann's commitment to advancing rare disease access and P4A's thought leadership in regulatory-HTA integration.
"FSHD is a relentlessly progressive rare disease with no treatment options to date. By the time both ATMP and orphan drug therapies for FSHD have completed clinical development, they will be subject to JCA." said Sophie Schmitz, Managing Partner at Partners4Access. "This work provides useful insights for drug developers on the PICOs that may be selected by member states."
The International Research Congress for FSHD will be held in Amsterdam from June 12-13, 2025.
About Partners4Access
Partners4Access is a global leader in pharmaceutical innovation and orphan drug access. With a global presence, we are dedicated to supporting our clients and access to life-changing therapies to patients worldwide.
Find out more at www.partners4access.com
Johann's poster, titled "Optimising Clinical Development Programs for FSHD Therapies in Preparation for Joint Clinical Assessment (JCA) in Europe," explores strategic approaches to aligning FSHD therapy development with the evolving regulatory and health technology assessment (HTA) landscape. As the European Union moves toward centralized JCA processes, Johann's research highlights critical considerations for developers navigating both clinical efficacy and payer expectations.
More on eTradeWire News
- U.S. Behavioral Case Study Challenges Scientific Basis of XL Bully Ban in UK and Ireland
- Sharone Reid of Focus & Fabulous Events named People's Choice Award Nominee by the MBL
- PitPat Launches "Road to London 2KM" Global Online Race: A High-Speed Sprint to London
- Anna D. Banks Named L.E.A.D.S. Mentee of the Month for March 2026
- As AI Floods the Compliance Landscape, First Point Launches to Bring Back a Human Touch
The acceptance of this work at one of the leading global forums for FSHD research reflects both Johann's commitment to advancing rare disease access and P4A's thought leadership in regulatory-HTA integration.
"FSHD is a relentlessly progressive rare disease with no treatment options to date. By the time both ATMP and orphan drug therapies for FSHD have completed clinical development, they will be subject to JCA." said Sophie Schmitz, Managing Partner at Partners4Access. "This work provides useful insights for drug developers on the PICOs that may be selected by member states."
The International Research Congress for FSHD will be held in Amsterdam from June 12-13, 2025.
About Partners4Access
Partners4Access is a global leader in pharmaceutical innovation and orphan drug access. With a global presence, we are dedicated to supporting our clients and access to life-changing therapies to patients worldwide.
Find out more at www.partners4access.com
Source: Partners4Access
Filed Under: Medical
0 Comments
Latest on eTradeWire News
- Website Development in Texas Texas Web Studios Powers Business Growth with Modern Digital Solutions
- Wix Web Designer New York: NY Web Experts Builds Modern Websites for Growing Businesses in 2026
- Join First Choice Neurology at the 2026 AAN Annual Meeting in Chicago
- U.S. Senate Candidate Alander Pulliam Issues Definitive Statement on Cryptocurrency and the Future
- Alander Pulliam Launches A&A Sports Group to Build Elite Athletes and Stronger Communities
- Over 300 Teens And Their Parents Shop at Prom Closet at Local YMCAS
- East Orange Leader Monique M. Lewis Receives Leadership Recognition Award
- 5th Annual Chicago Scavenger Hunt June 13 & 14
- Keenethics enters the ChatGPT Apps ecosystem as a new growth opportunity for businesses
- Garden Lights Direct and Ripon Lighting Launch New Solar Wall Lights Collection
- Jeff Miller Is the Most Qualified and Most Experienced and Most Efficient Candidate for Clark County
- 'Into the Cole: A Tribute to Nat King Cole' Arrives at Catalina Jazz Club starring Aaron Akins
- Westlake Lutheran Academy Breaks Ground on New Campus Expansion
- Learn Window Tint in Winnipeg with the Tint Academy - Upcoming Schedule
- May 2nd Dark Hour's Halfway to Halloween Spring Market
- New and Returning Events for 2026 Season
- New Fairy Lights Range Announcement by Garden Lights Direct
- ConnectNeighbors.com Expands Nationwide Network to 92,000+ Neighborhoods as Traffic Nears 1 Million Monthly Views
- Leading PEO INFINITI HR Announces Industry Veteran, Javier Ramirez, as New COO
- One Clean Carton® with Sustainable Paperboard Tests Safe for Secondary Packaging